Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 214.00 | 249.25 | 0.8586 | 0.7030 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 241.00 | 249.25 | 0.9669 | 0.9303 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 297.00 | 249.25 | 1.1916 | 1.4060 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 312.50 | 129.17 | 228.00 | 249.25 | 0.9147 | 0.8206 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 312.50 | 129.17 | 266.00 | 249.25 | 1.0672 | 1.1420 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 292.00 | 249.25 | 1.1715 | 1.3633 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 312.50 | 129.17 | 313.00 | 249.25 | 1.2558 | 1.5429 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 340.00 | 249.25 | 1.3641 | 1.7747 | |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 312.50 | 129.17 | 344.00 | 249.25 | 1.3801 | 1.8091 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 312.50 | 129.17 | 110.00 | 249.25 | 0.4413 | -0.1558 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 312.50 | 129.17 | 304.00 | 249.25 | 1.2197 | 1.4658 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 320.00 | 249.25 | 1.2839 | 1.6029 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 312.50 | 129.17 | 105.00 | 249.25 | 0.4213 | -0.1962 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 312.50 | 129.17 | 410.00 | 249.25 | 1.6449 | 2.3802 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 330.00 | 249.25 | 1.3240 | 1.6887 | |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 305.00 | 249.25 | 1.2237 | 1.4744 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 399.00 | 249.25 | 1.6008 | 2.2847 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 312.50 | 129.17 | 248.00 | 249.25 | 0.9950 | 0.9894 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 312.50 | 129.17 | 121.00 | 249.25 | 0.4855 | -0.0666 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 170.00 | 249.25 | 0.6821 | 0.3360 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 188.00 | 249.25 | 0.7543 | 0.4855 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 379.00 | 644.25 | 0.5883 | 0.3084 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 551.00 | 644.25 | 0.8553 | 0.7649 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 625.00 | 270.83 | 557.00 | 644.25 | 0.8646 | 0.7802 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 625.00 | 270.83 | 536.00 | 644.25 | 0.8320 | 0.7264 |